A preliminary, randomized, multicenter study comparing intravenous immunoglobulin, plasma exchange, and immune adsorption in Guillain-Barré syndrome

European Neurology

Volumn 46, Issue 2, 2001, Pages 107-109

  Diener, Hans Christoph ^a   Haupt, Walter F ^a   Kloss, Thomas M ^a   Rosenow, F ^b   Philipp, Thomas ^a   Koeppen, Susanne ^a   Vietorisz, Auli ^c  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G;

ADSORPTION; ARTICLE; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG EFFICACY; GUILLAIN BARRE SYNDROME; HEART ARRHYTHMIA; HUMAN; IMMUNOADSORPTION; PHASE 3 CLINICAL TRIAL; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0034865071     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000050777     Document Type: Article

References (5)

1. Role of replacement fluids
2. Plasma exchange and acute Guillain-Barré syndrome
3. Plasma exchange and selective adsorption in Guillain-Barré syndrome - A comparison of therapies by clinical course and side-effects
4. A randomized trail comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome
5. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome